BMS announces new head of major markets

Dr Monica Shaw has joined the commercial leadership team of US pharma major Bristol Myers Squibb’s (NYSE: BMY) as senior vice president, major markets.

In this role, Dr Shaw oversees the company’s largest markets outside of the USA, including Canada and Western Europe, all of which are significant growth drivers for Bristol Myers as the company launches new innovative medicines, while carrying out our mission to help patients prevail over serious disease.

Dr Shaw joins BMS from Swedish oncology focused biotech Oncopeptides (Nasdaq Stockholm: ONCO), where she served as chief executive. Previously, she held international leadership roles at GSK (LSE: GSK)/ViiV Healthcare, Merck Serono and Novartis (NOVN: VX) and has launched more than 15 products through Phase III to commercialization. Dr Shaw brings broad experience having worked across immunology, dermatology, oncology, virology, neurology and rare diseases. She began her career as a physician with the National Health Service in the UK, working across different hospital specialties.